MedPath

A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Registration Number
NCT04008030
Lead Sponsor
Bristol-Myers Squibb
Brief Summary

The main purpose of this study is to compare the clinical benefit, as measured by Progression-Free Survival (PFS), Objective Response Rate (ORR), and Overall Survival (OS), achieved by nivolumab in combination with ipilimumab or by nivolumab monotherapy in participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) metastatic colorectal cancer (mCRC). This study will also compare nivolumab plus ipilimumab combination vs chemotherapy for treatment of MSI-H/dMMR mCRC participants.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
1147
Inclusion Criteria
  • Histologically confirmed recurrent or metastatic colorectal cancer (CRC) irrespective of prior treatment history with chemotherapy and/or targeted agents not amenable to surgery (Applicable only during Part 1 enrollment of the study)
  • Histologically confirmed recurrent or metastatic CRC with no prior treatment history with chemotherapy and/or targeted agents for metastatic disease and not amenable to surgery (Applicable during Part 2 enrollment of the study)
  • Known tumor microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) status per local standard of practice
  • Eastern cooperative oncology group (ECOG) performance status lower than or equal to 1
Exclusion Criteria
  • An active, known or suspected autoimmune disease
  • History of interstitial lung disease or pneumonitis
  • Known history of positive test for human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS)

Other protocol-defined inclusion/exclusion criteria apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm A: Nivolumab MonotherapyNivolumab-
Arm B: Nivolumab + Ipilimumab CombinationIpilimumab-
Arm B: Nivolumab + Ipilimumab CombinationNivolumab-
Arm C: Investigator's Choice ChemotherapyLeucovorinParticipants in Arm C would be allowed to receive Nivolumab + Ipilimumab if they progress
Arm C: Investigator's Choice ChemotherapyFluorouracilParticipants in Arm C would be allowed to receive Nivolumab + Ipilimumab if they progress
Arm C: Investigator's Choice ChemotherapyIrinotecanParticipants in Arm C would be allowed to receive Nivolumab + Ipilimumab if they progress
Arm C: Investigator's Choice ChemotherapyOxaliplatinParticipants in Arm C would be allowed to receive Nivolumab + Ipilimumab if they progress
Arm C: Investigator's Choice ChemotherapyBevacizumabParticipants in Arm C would be allowed to receive Nivolumab + Ipilimumab if they progress
Arm C: Investigator's Choice ChemotherapyCetuximabParticipants in Arm C would be allowed to receive Nivolumab + Ipilimumab if they progress
Primary Outcome Measures
NameTimeMethod
Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) (arm B vs A, all lines, centrally confirmed)Up to 5 years
PFS by BICR (arm B vs C, 1L, centrally confirmed)Up to 5 years
Secondary Outcome Measures
NameTimeMethod
OS (arm B vs A, 1L, centrally confirmed)Up to 5 years
Overall Survival (OS) (arm B vs A, all lines, centrally confirmed)Up to 5 years
OS (arm A vs C, 1L, centrally confirmed)Up to 5 years
PFS by Investigator (arm A, B and C, 1L, centrally confirmed)Up to 5 years
PFS by BICR among all randomized participants who have not received prior treatment (arm B vs A, 1L, per local testing)Up to 5 years
PFS by Investigator Assessment (arm B vs A, all lines, centrally confirmed)Up to 5 years
PFS by BICR among all randomized participants (arm B vs A, all lines, per local testing)Up to 5 years
ORR by BICR (arm B vs A, 1L, centrally confirmed)Up to 5 years
ORR by BICR (arm A vs C, 1L, centrally confirmed)Up to 5 years
Overall Response Rate (ORR) by BICR (arm B vs A, all lines, centrally confirmed)Up to 5 years
PFS by BICR (arm A vs C, 1L, centrally confirmed)Up to 5 years
OS (arm B vs C, 1L, centrally confirmed)Up to 5 years
PFS by BICR (arm B vs A, 1L, centrally confirmed)Up to 5 years
ORR by BICR (arm B vs C, 1L, centrally confirmed)Up to 5 years
PFS by BICR (arm B vs C, 1L, by each central test)Up to 5 years
PFS by BICR (arm B vs A, all lines, by each central test)Up to 5 years
ORR by BICR (crossover cohort, centrally confirmed)Up to 5 years
PFS by BICR among all randomized participants who have not received prior treatment (arm B vs C, 1L, per local testing)Up to 5 years
PFS by BICR (crossover cohort, centrally confirmed)Up to 5 years

Trial Locations

Locations (158)

Local Institution - 0084

🇦🇷

Buenos Aires, Argentina

Local Institution - 0100

🇦🇷

Caba, Argentina

Local Institution - 0072

🇦🇷

Caba, Argentina

Local Institution - 0068

🇦🇹

Linz, Austria

Local Institution - 0120

🇦🇹

Salzburg, Austria

Local Institution - 0067

🇦🇹

Wiener Neustadt, Austria

Local Institution - 0065

🇦🇹

Wien, Austria

Local Institution - 0153

🇨🇳

Guangzhou, Guangdong, China

Local Institution - 0149

🇨🇳

Guangzhou, Guangdong, China

Local Institution - 0164

🇨🇳

Changchun, Jilin, China

Local Institution - 0137

🇨🇳

Hangzhou, Zhejiang, China

Local Institution - 0086

🇨🇿

Olomouc, Czechia

Local Institution - 0038

🇩🇰

Herlev, Denmark

Local Institution - 0036

🇩🇰

Vejle, Denmark

Local Institution - 0028

🇫🇷

Besancon Cedex, France

Local Institution - 0029

🇫🇷

Lyon Cedex 08, France

Local Institution - 0183

🇫🇷

Lyon, France

Local Institution - 0066

🇫🇷

Marseille, France

Local Institution - 0030

🇫🇷

Montpellier, France

Local Institution - 0032

🇫🇷

Nantes, France

Local Institution - 0027

🇫🇷

Paris, France

Local Institution - 0061

🇫🇷

Pessac Cedex, France

Local Institution - 0031

🇫🇷

Poitiers, France

Local Institution - 0184

🇫🇷

Strasbourg, France

Local Institution - 0040

🇫🇷

Toulouse, France

Local Institution - 0042

🇩🇪

Dresden, Germany

Local Institution - 0007

🇩🇪

Essen, Germany

Local Institution - 0043

🇩🇪

Hamburg, Germany

Local Institution - 0117

🇩🇪

Hamburg, Germany

Local Institution - 0008

🇩🇪

Hannover, Germany

Local Institution - 0009

🇩🇪

Heidelberg, Germany

Local Institution - 0044

🇩🇪

Marburg, Germany

Local Institution - 0010

🇩🇪

Munich, Germany

Local Institution - 0035

🇳🇴

Oslo, Norway

Local Institution - 0058

🇵🇷

Rio Piedras, Puerto Rico

Local Institution - 0076

🇷🇴

Cluj-Napoca, Cluj, Romania

Local Institution - 0081

🇷🇴

Craiova, Dolj, Romania

Local Institution - 0168

🇷🇴

Brasov, Romania

Local Institution - 0080

🇷🇴

Bucharest, Romania

Local Institution - 0205

🇷🇴

Iași, Romania

Local Institution - 0089

🇷🇴

Suceava, Romania

Local Institution - 0211

🇨🇳

Lanzhou, Gansu, China

Local Institution - 0059

🇺🇸

Los Angeles, California, United States

Local Institution - 0130

🇺🇸

Sacramento, California, United States

Local Institution - 0103

🇺🇸

Denver, Colorado, United States

Local Institution - 0119

🇺🇸

Arlington Heights, Illinois, United States

Local Institution - 0060

🇺🇸

New York, New York, United States

Local Institution - 0105

🇺🇸

Portland, Oregon, United States

Local Institution - 0121

🇺🇸

Pittsburgh, Pennsylvania, United States

Local Institution - 0106

🇺🇸

Dallas, Texas, United States

Local Institution - 0104

🇺🇸

Roanoke, Virginia, United States

Local Institution - 0073

🇦🇷

Ciudad Autonoma Beunos Aires, Buenos Aires, Argentina

Local Institution - 0074

🇦🇷

Viedma, RIO Negro, Argentina

Local Institution - 0019

🇦🇺

Westmead, New South Wales, Australia

Local Institution - 0053

🇦🇺

Woolloongabba, Queensland, Australia

Local Institution - 0018

🇦🇺

Elizabeth Vale, South Australia, Australia

Local Institution - 0041

🇦🇺

Clayton, Victoria, Australia

Local Institution - 0017

🇦🇺

Heidelberg, Victoria, Australia

Local Institution - 0064

🇦🇹

Graz, Austria

Local Institution - 0045

🇧🇪

Bonheiden, Antwerpen, Belgium

Local Institution - 0025

🇧🇪

Anderlecht, Bruxelles-Capitale, Région De, Belgium

Local Institution - 0024

🇧🇪

Leuven, Belgium

Local Institution - 0096

🇧🇷

Ipatinga, Minas Gerais, Brazil

Local Institution - 0200

🇧🇷

Natal, RIO Grande DO Norte, Brazil

Local Institution - 0192

🇧🇷

Porto Alegre, RIO Grande DO SUL, Brazil

Local Institution - 0102

🇧🇷

Barretos, Sao Paulo, Brazil

Local Institution - 0095

🇧🇷

Sao Paulo, São Paulo, Brazil

Local Institution - 0094

🇧🇷

São José do Rio Preto, São Paulo, Brazil

Local Institution - 0199

🇧🇷

Rio de Janeiro, Brazil

Local Institution - 0193

🇧🇷

São Paulo, Brazil

Local Institution - 0011

🇨🇦

Edmonton, Alberta, Canada

Local Institution - 0039

🇨🇦

Vancouver, British Columbia, Canada

Local Institution - 0013

🇨🇦

Toronto, Ontario, Canada

Local Institution - 0016

🇨🇦

Montreal, Quebec, Canada

Local Institution - 0015

🇨🇦

Sherbrooke, Quebec, Canada

Local Institution - 0071

🇨🇱

Santiago, Metropolitana, Chile

Local Institution - 0069

🇨🇱

Santiago, Metropolitana, Chile

Local Institution - 0070

🇨🇱

Independencia, Santiago, Chile

Local Institution - 0146

🇨🇳

Hefei, Anhui, China

Local Institution

🇨🇳

Fuzhou, Fujian, China

Local Institution - 0163

🇨🇳

Xiamen, Fujian, China

Local Institution - 0207

🇨🇳

Zhangzhou, Fujian, China

Local Institution - 0158

🇨🇳

Foshan, Guangdong, China

Local Institution - 0167

🇨🇳

Guangzhou, Guangdong, China

Local Institution - 0160

🇨🇳

Nanning, Guangxi, China

Local Institution - 0196

🇨🇳

Nanning, Guangxi, China

Local Institution - 0180

🇨🇳

Harbin, Heilongjiang, China

Local Institution - 0181

🇨🇳

Zhengzhou, Henan, China

Local Institution - 0197

🇨🇳

Changsha, Hunan, China

Local Institution - 0145

🇨🇳

Changzhou, Jiangsu, China

Local Institution - 0151

🇨🇳

Nanchang, Jiangxi, China

Local Institution - 0116

🇯🇵

Fukuoka-shi, Fukuoka, Japan

Local Institution - 0162

🇨🇳

Shenyang, Liaoning, China

Local Institution - 0188

🇨🇳

Xi'an, Shaanxi, China

Local Institution - 0210

🇨🇳

Jinan, Shandong, China

Local Institution - 0212

🇨🇳

Linyi, Shandong, China

Local Institution - 0154

🇨🇳

Qingdao, Shandong, China

Local Institution - 0165

🇨🇳

Yantai, Shandong, China

Local Institution - 0143

🇨🇳

Shanghai, Shanghai, China

Local Institution - 0131

🇨🇳

Shanghai, Shanghai, China

Local Institution - 0221

🇨🇳

Shanghai, Shanghai, China

Local Institution - 0195

🇨🇳

Kunming, Yunnan, China

Local Institution - 0206

🇨🇳

Ningbo, Zhejiang, China

Local Institution - 0087

🇨🇿

Brno, Czechia

Local Institution - 0085

🇨🇿

Hradec Kralove, Czechia

Local Institution - 0088

🇨🇿

Novy Jicin, Czechia

Local Institution - 0176

🇫🇷

Limoges, Haute-Vienne, France

Local Institution - 0138

🇫🇷

Lille, Nord, France

Local Institution - 0186

🇫🇷

Bayonne, France

Local Institution - 0222

🇬🇷

Athens, Greece

Local Institution - 0123

🇬🇷

Athens, Greece

Local Institution - 0125

🇬🇷

Heraklion, Greece

Local Institution - 0124

🇬🇷

Holargos, Greece

Local Institution - 0126

🇬🇷

Ioannina, Greece

Local Institution - 0091

🇮🇪

Dublin 8, Dublin, Ireland

Local Institution - 0022

🇮🇪

Dublin, Ireland

Local Institution - 0026

🇮🇪

Limerick, Ireland

Local Institution - 0055

🇮🇹

Catania, Italy

Local Institution - 0003

🇮🇹

Genova, Italy

Local Institution - 0001

🇮🇹

Milan, Italy

Local Institution - 0004

🇮🇹

Napoli, Italy

Local Institution - 0002

🇮🇹

Padova, Italy

Local Institution - 0054

🇮🇹

Roma, Italy

Local Institution - 0109

🇯🇵

Nagoya-shi, Aichi, Japan

Local Institution - 0112

🇯🇵

Chiba-shi, Chiba, Japan

Local Institution - 0107

🇯🇵

Kashiwa-shi, Chiba, Japan

Local Institution - 0132

🇯🇵

Matsuyama, Ehime, Japan

Local Institution - 0174

🇯🇵

Sapporo-shi, Hokkaido, Japan

Local Institution - 0128

🇯🇵

Kanazawa-city, Ishikawa, Japan

Local Institution - 0111

🇯🇵

Kawasaki, Kanagawa, Japan

Local Institution - 0175

🇯🇵

Yokohama, Kanagawa, Japan

Local Institution - 0133

🇯🇵

Kumamoto-shi, Kumamoto, Japan

Local Institution - 0189

🇯🇵

Osaki, Miyagi, Japan

Local Institution - 0177

🇯🇵

Kurashiki, Okayama, Japan

Local Institution - 0115

🇯🇵

Suita-shi, Osaka, Japan

Local Institution - 0187

🇯🇵

Hidaka, Saitama, Japan

Local Institution - 0110

🇯🇵

Kitaadachigun, Saitama, Japan

Local Institution - 0108

🇯🇵

Sunto-gun, Shizuoka, Japan

Local Institution - 0118

🇯🇵

Chuo-ku, Tokyo, Japan

Local Institution - 0113

🇯🇵

Koto-ku, Tokyo, Japan

Local Institution - 0129

🇯🇵

Minato-ku, Tokyo, Japan

Local Institution - 0114

🇯🇵

Osaka, Japan

Local Institution - 0052

🇳🇱

Amsterdam, Noord-Holland, Netherlands

Local Institution - 0051

🇳🇱

Amsterdam, Noord-Holland, Netherlands

Local Institution - 0050

🇳🇱

Utrecht, Netherlands

Local Institution - 0033

🇳🇴

Bergen, Norway

Local Institution - 0034

🇳🇴

Lorenskog, Norway

Local Institution - 0056

🇪🇸

Badalona, Barcelona [Barcelona], Spain

Local Institution - 0173

🇪🇸

A Coruna, Spain

Local Institution - 0006

🇪🇸

Barcelona, Spain

Local Institution - 0005

🇪🇸

Madrid, Spain

Local Institution - 0172

🇪🇸

Malaga, Spain

Local Institution - 0063

🇪🇸

Sevilla, Spain

Local Institution - 0171

🇪🇸

Valencia, Spain

Local Institution - 0092

🇹🇷

Adana, Turkey

Local Institution - 0101

🇹🇷

Istanbul, Turkey

Local Institution - 0127

🇬🇧

London, United Kingdom

Local Institution - 0049

🇬🇧

Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath